The Effects of Sex and Age Differences on Gastric Cancer : a Retrospective Study
April 12, 2023 updated by: Nayoung Kim, Seoul National University Bundang Hospital
The Effects of Sex and Age Differences on Gastric Cancer in Terms of Incidence of Histologic Subtypes and Survival Rate: a Retrospective Study
Gastric cancer (GC) is more prevalent in males than in females.
One of these differences could be the effect of sex hormones such as estrogens.
However, few reports have been reported regarding sex and age differences of incidence and survival of GC.
The aim of this study was to evaluate the effect of sex and age on the incidence and survival of GC.
And we would like to further analyze single GC and synchronous multiple GC, EBV, etc.
Study Overview
Study Type
Observational
Enrollment (Actual)
14900
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Probability Sample
Study Population
patients diagnosed with Gastric cancer at the Seoul National University Bundang Hospital were analyzed retrospectively from May 2003 to February 2020.
The data were collected using clinical data warehouses (CDW), and electronic medical records (EMR) were reviewed as needed.
Description
Inclusion Criteria:
- Clinical diagnosis of Gastric cancer
exclusion criteria:
- Gastric MALTOMA
- Gastric Lymphoma
- Gastrointestinal stromal tumors (GISTs)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Survival rate
Time Frame: up to 120 months
|
Survival rate of gastric cancer on sex and age
|
up to 120 months
|
|
histologic type
Time Frame: about 18 years
|
histologic type of gastric cancer on sex and age
|
about 18 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2003
Primary Completion (Actual)
September 1, 2021
Study Completion (Actual)
January 1, 2022
Study Registration Dates
First Submitted
July 13, 2021
First Submitted That Met QC Criteria
July 15, 2021
First Posted (Actual)
July 22, 2021
Study Record Updates
Last Update Posted (Actual)
April 13, 2023
Last Update Submitted That Met QC Criteria
April 12, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B-2006-618-004
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.